ObsEva SA: ObsEva Announces Update Towards its Strategic Reo

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - March 13, 2023 - ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing

Related Keywords

Geneva , Genè , Switzerland , Ladonchamps , Lorraine , France , Swiss , Dennis Riedl , Ernest Loumaye , Shauna Dillon , Annette Clancy , Obseva Executive Committee , University In Lyon , Swiss Exchange , Nasdaq , Interim Chairman , General Meeting , Fabien De Ladonchamps , Chief Executive Officer , Executive Committee , Chief Administrative Officer , Interim Chief Financial , Addex Therapeutics , Interim Chief Executive Officer , Will Brown , Interim Board , Nasdaq Capital Market , Note Regarding Forward Looking Statements , Private Securities Litigation Reform Act , Risk Factors , Annual Report , Obseva , Nnounces , Update , Cowards , Strategic , Reorganization , Consolidate , Operations ,